Illumina Inc (ILMN)

Exchange
NASDAQ
Symbol
ILMN
Sector
Life Sciences
Industry
Laboratory Analytical Instruments
Description
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    156.14
  • High
    156.51
  • Low
    147.87
  • Close
    151.83
  • Volume
    2,834,480

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.00
Receivables turnover
6.14
Payables turnover
7.18
Working capital turnover
4.33
Days of inventory on hand (DOH)
121.81
Days of sales outstanding (DSO)
59.48
Number of days of payables
50.84
Fixed asset turnover
4.47
Total asset turnover
0.45
 Liquidity ratios
Current ratio
1.66
Quick ratio
1.14
Cash ratio
0.67
Cash conversion cycle
130.45
 Solvency ratios
Debt-to-assets ratio
0.15
Debt-to-capital ratio
0.21
Debt-to-equity ratio
0.26
Financial leverage ratio
1.76
Interest coverage
-13.68
 Profitability ratios
Gross profit margin
60.95%
Operating profit margin
-23.76%
Pretax margin
-24.78%
Net profit margin
-25.75%
Operating return on assets (Operating ROA)
-10.58%
Return on assets (ROA)
-11.47%
Return on total capital
-14.38%
Return on equity (ROE)
-20.19%